Russia has already approved two Covid-19 vaccines, including the Sputnik V shot, developed by Moscow’s Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results.
Original source: https://health.economictimes.indiatimes.com/news/pharma/81124396?utm_source=RSS&utm_medium=ETRSS
